Testing novel genetic therapies for ACTA1 nemaline myopathy (NEM3) – harnessing patient cells

Project Details

StatusActive
Effective start/end date5/08/204/08/22

Funding

  • A Foundation Building Strength Inc: AUD52,118.00
  • A Foundation Building Strength Inc: AUD119,932.00
  • A Foundation Building Strength Inc: AUD64,334.00